<正> There appear to be three principle forces driving the tuture of new drug development: under-standing the genome-transcrip-tomeproteme correlations, under-standing and mapping protein posttranslational modification(PTM)pathways, and integration of mass spectrometry(MS) techniques into routine protein identification and characterization.